GL1X · GenesisL1 explorer

MolNFT v1 · #105900 · protein

The yellow crystal structure of pyridoxal-dependent decarboxylase from sphaerobacter thermophilus dsm 20745

4RIT: “The yellow crystal structure of pyridoxal-dependent decarboxylase from sphaerobacter thermophilus dsm 20745”. X-ray diffraction, 1 ligand (CL), 8 pockets (best druggability 0.66). MolNFT v1 #105900 on GenesisL1: 3D structure…

PDB
4RIT
Type
protein
Length
930 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pyridoxal-dependent decarboxylase
EC
4.1.1.15
UniProt
D1C7D8
Ligands
CL
Pockets
8 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BPyridoxal-dependent decarboxylase (EC 4.1.1.15)protein46945% helix, 13% strandD1C7D8
APyridoxal-dependent decarboxylase (EC 4.1.1.15)protein46145% helix, 13% strandD1C7D8

Ligands and binding sites

  • CL · Chloride ion · ion · 3 copies · chains B, A
  • GOL · Glycerol · additive · 11 copies · chains B, A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · 3 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15260.660.7848empty
24400.650.7844empty
3660.450.8215GOL
4830.440.8019empty
51580.440.7527empty

Interfaces

1 interface between chains.

  • B–A · 6698 Ų buried · 85 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 26 modified (engineered, cofactor).

Compared structures

  • 4RIT · The yellow crystal structure of pyridoxal-dependent decarboxylase from sphaerobacter… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.